Risk Haplotype of BTNL2 Predisposes Male Patients to NSTEMI: A Genetic and Functional Study

Read full text Summarise with VIRAT
Authors: Anna Inkeri Lokki, Juha P. Sinisalo, Kitty Aierken, Marita Kalaoja, Mitja Lääperi, Jessica Koski, Veikko V Salomaa, Markus Perola, Johannes Kettunen, Markku T Varjosalo, Hanna Jarva, Pirkko J. Pussinen
+5 more Sarah R. Klein, Katariina Öörni, Mikko Ilari Mäyränpää, Steven J. Mack, Marja‐Liisa Lokki
Cited by: 0
References: 56

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Immunogenetic factors constitute major pathways contributing to the susceptibility to atherosclerosis and coronary artery disease. Through targeted whole-genome sequencing and replications in sex-specific cohorts with ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI) we discovered a novel haplotype in the butyrophilin-like 2 (BTNL2) gene that predisposes men to NSTEMI. This risk haplotype is associated with the number and composition of extra-large high-density lipoproteins, and enhanced aggregation of low-density lipoproteins. Affected individuals have changes in BTNL2 expression. Furthermore, patients with risk haplotype and decreased BTNL2 serum concentration had improved survival. Our results identify BTNL2 as a compelling candidate gene in men with NSTEMI and suggest a previously unrecognized immuno-lipid regulatory mechanism contributing to disease susceptibility and outcome. The study highlights the importance of precise clinical characterisation and specific diagnoses in genetic studies of cardiovascular diseases.

Fields of Study & Subjects

Genetic Associations and Epidemiology Atherosclerosis and Cardiovascular Diseases Lipoproteins and Cardiovascular Health

Publication details

Journal / source
Research Square
Publication date
25 March 2026
Language
EN
Document type
Preprint